Self-Guided CBT Mobile App for Treatment-Resistant Panic Disorder (CBT) Cognitive Behavioral Therapy
(CBT)
Efficacy of a Self-Guided Cognitive Behavioral Therapy Protocol Via Mobile Application in Patients With Treatment-Resistant Panic Disorder: An Open-Label Trial
1 other identifier
observational
45
1 country
1
Brief Summary
Treatment-resistant panic disorder (TRPD) is characterized by persistent panic symptoms despite adequate pharmacological and/or psychotherapeutic treatment. This open-label study is designed to evaluate a self-guided cognitive behavioral therapy (CBT) protocol delivered via a mobile application for adults with TRPD. The intervention consists of eight weekly sessions covering psychoeducation, panic cycle interruption, cognitive restructuring, relaxation techniques, assertiveness training, behavioral strategies, and life reorganization. An avatar is incorporated to enhance engagement and simulate therapeutic presence. Participants continue their usual psychiatric follow-up and pharmacological treatment throughout the study. Outcomes are assessed at baseline and after completion of the intervention using validated measures of panic severity, anxiety, depression, mindfulness, coping strategies, quality of life, and affect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2025
CompletedFirst Submitted
Initial submission to the registry
August 16, 2025
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedFebruary 6, 2026
May 1, 2025
7 months
August 16, 2025
January 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Beck Anxiety Inventory (BAI) Total Score
The Beck Anxiety Inventory (BAI) is a 21-item self-report questionnaire designed to assess the severity of anxiety symptoms. Total scores range from 0 to 63, with higher scores indicating greater anxiety severity. The BAI is administered to all participants at baseline and at the end of the intervention. Unit of Measure: Points on a scale (0-63)
Baseline (Week 1) and Post-intervention (Week 8)
Secondary Outcomes (1)
Beck Depression Inventory-II (BDI-II) Total Score
Baseline (Week 1) and Post-intervention (Week 8)
Other Outcomes (5)
Mindful Attention Awareness Scale (MAAS) Total Score
Baseline (Week 1) and Post-intervention (Week 8)
WHOQOL-BREF Physical Health Domain Score
Baseline (Week 1) and Post-intervention (Week 8)
WHOQOL-BREF Social Relationships Domain Score
Baseline (Week 1) and Post-intervention (Week 8)
- +2 more other outcomes
Interventions
Eight-session manualized CBT protocol delivered via mobile app, including psychoeducation, cognitive restructuring, relaxation, behavioral activation, assertiveness, and life reorganization, with avatar interface to enhance engagement.
Eligibility Criteria
Patients in the panic and respiratory of the Federal University of Rio de Janeiro
You may qualify if:
- Age 18-60
- DSM-5 diagnosis of TRPD confirmed by psychiatrist
- Ongoing psychiatric follow-up
- Current pharmacological treatment for PD
- Ability to use smartphone/app
You may not qualify if:
- No PD diagnosis
- Other primary psychiatric disorder
- Severe cognitive impairment
- Inability to use the app
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Luisa
Rio de Janeiro, Rio de Janeiro, Brazil
Related Publications (18)
Planert J, Machulska A, Hildebrand AS, Roesmann K, Otto E, Klucken T. Self-guided digital treatment with virtual reality for panic disorder and agoraphobia: a study protocol for a randomized controlled trial. Trials. 2022 May 21;23(1):426. doi: 10.1186/s13063-022-06366-x.
PMID: 35597959RESULTPauley D, Cuijpers P, Papola D, Miguel C, Karyotaki E. Two decades of digital interventions for anxiety disorders: a systematic review and meta-analysis of treatment effectiveness. Psychol Med. 2023 Jan;53(2):567-579. doi: 10.1017/S0033291721001999. Epub 2021 May 28.
PMID: 34047264RESULTJung HW, Jang KW, Nam S, Kim A, Lee J, Ahn ME, Lee SK, Kim YJ, Shin JK, Roh D. Digital Cognitive Behavioral Therapy for Panic Disorder and Agoraphobia: A Meta-Analytic Review of Clinical Components to Maximize Efficacy. J Clin Med. 2025 Mar 6;14(5):1771. doi: 10.3390/jcm14051771.
PMID: 40095899RESULTModesto-Lowe V, Adams S, Rossi A. Smartphone Applications: Therapy at Your Fingertips. Prim Care Companion CNS Disord. 2024 Aug 20;26(4):24lr03754. doi: 10.4088/PCC.24lr03754. No abstract available.
PMID: 39178019RESULTOlthuis JV, Watt MC, Bailey K, Hayden JA, Stewart SH. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2016 Mar 12;3(3):CD011565. doi: 10.1002/14651858.CD011565.pub2.
PMID: 26968204RESULTWatson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
PMID: 3397865RESULTBeck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
PMID: 3204199RESULTDevelopment of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998 May;28(3):551-8. doi: 10.1017/s0033291798006667.
PMID: 9626712RESULTKocalevent RD, Zenger M, Hinz A, Klapp B, Brahler E. Resilient coping in the general population: standardization of the brief resilient coping scale (BRCS). Health Qual Life Outcomes. 2017 Dec 28;15(1):251. doi: 10.1186/s12955-017-0822-6.
PMID: 29282066RESULTBrown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003 Apr;84(4):822-48. doi: 10.1037/0022-3514.84.4.822.
PMID: 12703651RESULTRus-Calafell M, Ehrbar N, Ward T, Edwards C, Huckvale M, Walke J, Garety P, Craig T. Participants' experiences of AVATAR therapy for distressing voices: a thematic qualitative evaluation. BMC Psychiatry. 2022 May 24;22(1):356. doi: 10.1186/s12888-022-04010-1.
PMID: 35610590RESULTJang B, Yuh C, Lee H, Shin YB, Lee HJ, Kang EK, Heo J, Cho CH. Exploring User Experience and the Therapeutic Relationship of Short-Term Avatar-Based Psychotherapy: Qualitative Pilot Study. JMIR Hum Factors. 2025 Feb 5;12:e66158. doi: 10.2196/66158.
PMID: 39924261RESULTPagliari C, Burton C, McKinstry B, Szentatotai A, David D, Serrano Blanco A, Ferrini L, Albertini S, Castro JC, Estevez S, Wolters M. Psychosocial implications of avatar use in supporting therapy for depression. Stud Health Technol Inform. 2012;181:329-33.
PMID: 22954882RESULTPelucio L, Quagliato LA, Cardoso A, Horato N, Nardi AE. Could the use of web-based applications assist in neuropsychiatric treatment? An umbrella review. BMC Psychol. 2025 Mar 26;13(1):302. doi: 10.1186/s40359-024-02263-x.
PMID: 40140888RESULTPelucio L, Quagliato LA, Nardi AE. Therapist-Guided Versus Self-Guided Cognitive-Behavioral Therapy: A Systematic Review. Prim Care Companion CNS Disord. 2024 Mar 21;26(2):23r03566. doi: 10.4088/PCC.23r03566.
PMID: 38512281RESULTFirth J, Torous J, Nicholas J, Carney R, Pratap A, Rosenbaum S, Sarris J. The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry. 2017 Oct;16(3):287-298. doi: 10.1002/wps.20472.
PMID: 28941113RESULTPasarelu CR, Andersson G, Bergman Nordgren L, Dobrean A. Internet-delivered transdiagnostic and tailored cognitive behavioral therapy for anxiety and depression: a systematic review and meta-analysis of randomized controlled trials. Cogn Behav Ther. 2017 Jan;46(1):1-28. doi: 10.1080/16506073.2016.1231219. Epub 2016 Oct 7.
PMID: 27712544RESULTBystritsky A. Treatment-resistant anxiety disorders. Mol Psychiatry. 2006 Sep;11(9):805-14. doi: 10.1038/sj.mp.4001852. Epub 2006 Jul 18.
PMID: 16847460RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luisa Pelucio, Dr
Universidade Federal do Rio de Janeiro
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 8 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
August 16, 2025
First Posted
February 6, 2026
Study Start
November 1, 2024
Primary Completion
May 30, 2025
Study Completion
May 30, 2025
Last Updated
February 6, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- For free time
- Access Criteria
- Just ask for contact information we share.
Study Protocol